The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

UK trumpets life sciences post-Brexit ‘sector deal’

Other projects highlighted in the document include a $100m contract from The Medicines Company to test a cholesterol-lowering drug at the University of Oxford’s clinical trials unit, a £40m ... This ecosystem will deliver for everyone, ”he added.

The Medicines Company strengthens board of directors

The Medicines Company strengthens board of directors. Paris Panayiotopoulos joins from ARIAD Pharmaceuticals. ... He said: “I am delighted to be joining The Medicines Company, especially at such an important time.

AZ gets EU green light for new antibiotic Zavicefta

The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of serious Gram-negative bacterial infections requiring hospitalization. ... The Medicines Company also has a candidate called RPXZ7009 in phase III trials

Deal Watch May 2016

The CRL refers to a manufacturing issue. ZS-9 was acquired when the company purchased ZS Pharma for $2.7bn. ... 911. The Medicines Company/ Chiesi. Product acquisition. Acquisition of cardiovascular assets Cleviprex, Kengreal and rights to Argatroban.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Training Manager - Surrey: Competitive Salary &Bonus

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Graduate Scientific Editor: DOE

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Medical Writer - Creative and Scientific Projects: DOE

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Medical Writer, MedComms Agency: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Healthcare PR Senior Account Manager: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Associate Scientific Director: Salary TBC

Senior Medical Writer: Salary is DOE

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Sudler London - Account Director: Competitive

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Market Access Consultant - Greater Manchester: Negotiable

Systematic Review Lead- London: Negotiable

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....